Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung

A. J. North, R. A. Star, T. S. Brannon, K. Ujiie, L. B. Wells, C. J. Lowenstein, S. H. Snyder, P. W. Shaul

Research output: Contribution to journalArticle

Abstract

The successful transition from fetal to neonatal life involves a marked decline in pulmonary vascular resistance which is modulated in part by endothelium-derived nitric oxide. To define the molecular processes which prepare the pulmonary circulation for nitric oxide mediation of vasodilatation at the time of birth, we determined the ontogeny of endothelial nitric oxide synthase (NOS-III) gene expression in lungs from fetal and newborn rats. Maturational changes in lung neuronal NOS (NOS-I) expression were also investigated; the latter isoform has been localized to rat bronchiolar epithelium. NOS proteins were examined by immunoblot analysis, and mRNA abundance was assessed in reverse transcription- polymerase chain reaction assays. Both NOS-III and NOS-I protein were detectable in 16-day fetal lung, they increased 3.8- and 3.1-fold, respectively, to maximal levels at 20 days of gestation (term = 22 day), and they fell postnatally (1-5 days). In parallel with the findings for NOS-III protein, NOS-III mRNA increased from 16 to 20 days gestation and fell after birth. In contrast, NOS-I mRNA abundance declined during late fetal life and rose postnatally. These findings were confirmed by Northern analyses. Thus NOS-III and NOS-I gene expression are developmentally regulated in rat lung, with maximal NOS-III and NOS-I protein present near term. The regulation of pulmonary NOS-III may primarily involve alterations in transcription or mRNA stability, whereas NOS-I expression in the maturing lung may also be mediated by additional posttranscriptional processes.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume266
Issue number6 10-6
StatePublished - 1994

Fingerprint

Nitric Oxide Synthase Type I
Gene Expression
Lung
Messenger RNA
Nitric Oxide
Proteins
Parturition
Pregnancy
Pulmonary Circulation
Nitric Oxide Synthase Type III
RNA Stability
Vasodilation
Vascular Resistance
Reverse Transcription
Protein Isoforms
Epithelium
Polymerase Chain Reaction

Keywords

  • bronchiolar epithelium
  • endothelium
  • persistent pulmonary hypertension of newborn
  • reverse-transcription polymerase chain reaction

ASJC Scopus subject areas

  • Cell Biology
  • Physiology
  • Pulmonary and Respiratory Medicine

Cite this

Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung. / North, A. J.; Star, R. A.; Brannon, T. S.; Ujiie, K.; Wells, L. B.; Lowenstein, C. J.; Snyder, S. H.; Shaul, P. W.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 266, No. 6 10-6, 1994.

Research output: Contribution to journalArticle

@article{c73f2acbe7514bcda3aabef2e00f298c,
title = "Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung",
abstract = "The successful transition from fetal to neonatal life involves a marked decline in pulmonary vascular resistance which is modulated in part by endothelium-derived nitric oxide. To define the molecular processes which prepare the pulmonary circulation for nitric oxide mediation of vasodilatation at the time of birth, we determined the ontogeny of endothelial nitric oxide synthase (NOS-III) gene expression in lungs from fetal and newborn rats. Maturational changes in lung neuronal NOS (NOS-I) expression were also investigated; the latter isoform has been localized to rat bronchiolar epithelium. NOS proteins were examined by immunoblot analysis, and mRNA abundance was assessed in reverse transcription- polymerase chain reaction assays. Both NOS-III and NOS-I protein were detectable in 16-day fetal lung, they increased 3.8- and 3.1-fold, respectively, to maximal levels at 20 days of gestation (term = 22 day), and they fell postnatally (1-5 days). In parallel with the findings for NOS-III protein, NOS-III mRNA increased from 16 to 20 days gestation and fell after birth. In contrast, NOS-I mRNA abundance declined during late fetal life and rose postnatally. These findings were confirmed by Northern analyses. Thus NOS-III and NOS-I gene expression are developmentally regulated in rat lung, with maximal NOS-III and NOS-I protein present near term. The regulation of pulmonary NOS-III may primarily involve alterations in transcription or mRNA stability, whereas NOS-I expression in the maturing lung may also be mediated by additional posttranscriptional processes.",
keywords = "bronchiolar epithelium, endothelium, persistent pulmonary hypertension of newborn, reverse-transcription polymerase chain reaction",
author = "North, {A. J.} and Star, {R. A.} and Brannon, {T. S.} and K. Ujiie and Wells, {L. B.} and Lowenstein, {C. J.} and Snyder, {S. H.} and Shaul, {P. W.}",
year = "1994",
language = "English (US)",
volume = "266",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 10-6",

}

TY - JOUR

T1 - Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung

AU - North, A. J.

AU - Star, R. A.

AU - Brannon, T. S.

AU - Ujiie, K.

AU - Wells, L. B.

AU - Lowenstein, C. J.

AU - Snyder, S. H.

AU - Shaul, P. W.

PY - 1994

Y1 - 1994

N2 - The successful transition from fetal to neonatal life involves a marked decline in pulmonary vascular resistance which is modulated in part by endothelium-derived nitric oxide. To define the molecular processes which prepare the pulmonary circulation for nitric oxide mediation of vasodilatation at the time of birth, we determined the ontogeny of endothelial nitric oxide synthase (NOS-III) gene expression in lungs from fetal and newborn rats. Maturational changes in lung neuronal NOS (NOS-I) expression were also investigated; the latter isoform has been localized to rat bronchiolar epithelium. NOS proteins were examined by immunoblot analysis, and mRNA abundance was assessed in reverse transcription- polymerase chain reaction assays. Both NOS-III and NOS-I protein were detectable in 16-day fetal lung, they increased 3.8- and 3.1-fold, respectively, to maximal levels at 20 days of gestation (term = 22 day), and they fell postnatally (1-5 days). In parallel with the findings for NOS-III protein, NOS-III mRNA increased from 16 to 20 days gestation and fell after birth. In contrast, NOS-I mRNA abundance declined during late fetal life and rose postnatally. These findings were confirmed by Northern analyses. Thus NOS-III and NOS-I gene expression are developmentally regulated in rat lung, with maximal NOS-III and NOS-I protein present near term. The regulation of pulmonary NOS-III may primarily involve alterations in transcription or mRNA stability, whereas NOS-I expression in the maturing lung may also be mediated by additional posttranscriptional processes.

AB - The successful transition from fetal to neonatal life involves a marked decline in pulmonary vascular resistance which is modulated in part by endothelium-derived nitric oxide. To define the molecular processes which prepare the pulmonary circulation for nitric oxide mediation of vasodilatation at the time of birth, we determined the ontogeny of endothelial nitric oxide synthase (NOS-III) gene expression in lungs from fetal and newborn rats. Maturational changes in lung neuronal NOS (NOS-I) expression were also investigated; the latter isoform has been localized to rat bronchiolar epithelium. NOS proteins were examined by immunoblot analysis, and mRNA abundance was assessed in reverse transcription- polymerase chain reaction assays. Both NOS-III and NOS-I protein were detectable in 16-day fetal lung, they increased 3.8- and 3.1-fold, respectively, to maximal levels at 20 days of gestation (term = 22 day), and they fell postnatally (1-5 days). In parallel with the findings for NOS-III protein, NOS-III mRNA increased from 16 to 20 days gestation and fell after birth. In contrast, NOS-I mRNA abundance declined during late fetal life and rose postnatally. These findings were confirmed by Northern analyses. Thus NOS-III and NOS-I gene expression are developmentally regulated in rat lung, with maximal NOS-III and NOS-I protein present near term. The regulation of pulmonary NOS-III may primarily involve alterations in transcription or mRNA stability, whereas NOS-I expression in the maturing lung may also be mediated by additional posttranscriptional processes.

KW - bronchiolar epithelium

KW - endothelium

KW - persistent pulmonary hypertension of newborn

KW - reverse-transcription polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0028321813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028321813&partnerID=8YFLogxK

M3 - Article

VL - 266

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6 10-6

ER -